Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IOVA stock hub

Iovance Biotherapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IOVAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IOVA

In the news

Latest news · IOVA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-47.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-28.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IOVA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001425205
Company name	Iovance Biotherapeutics, Inc.
Country	United States
Country code	US
Cusip	462260100
Employees	975
Employees Change	137%
Employees Change Percent	16.35
Enterprise value	$1.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US4622601007
Last refreshed	2026-05-10
Market cap	$1.6B
Market cap category	Small-Cap
Price	$3.62
Price currency	USD
Rev Per Employee	292,931.28x
Sector	Healthcare
Sic	2836
Symbol	IOVA
Website	https://www.iovance.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-21.89%
EV Sales Forward	3.11x
EV/Sales	4.73x
FCF yield	-18.87%
P/B ratio	2.2x
P/S ratio	5.66x
PS Forward	3.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-125.36%
EBITDA Margin	-112.61%
Gross margin	39.44%
Gross Profit	$112.6M
Gross Profit Growth	34.13%
Gross Profit Growth Q	337.77%
Net Income	$-353.9M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-124.21%
Profit Margin	-123.9%
Profit Per Employee	$-362,933
ROA	-23.65
Roa5y	-31.74
ROCE	-44.97
ROE	-47.51
Roe5y	-63.81
ROIC	-28.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.58%
Cagr15y	-20.95%
Cagr1y	15.67%
Cagr3y	-19.15%
Cagr5y	-33.83%
EPS Growth Quarters	13
EPS Growth Years	3
Revenue Growth	34.29x
Revenue Growth Q	44.82x
Revenue Growth Quarters	8x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.3
Assets	$925.7M
Cash	$313.4M
Current Assets	$466.5M
Current Liabilities	$129.4M
Debt	$47.8M
Debt Equity	$0.07
Equity	$721.8M
Liabilities	$203.9M
Long Term Assets	$459.2M
Long Term Liabilities	$74.5M
Net Cash	$265.7M
Net Cash By Market Cap	$16.44
Net Cash Growth	-13.18%
Net Debt Equity	$-0.37
Tangible Book Value	$452.6M
Tangible Book Value Per Share	$1.03
WACC	7.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.6
Inventory Turnover	2.79
Net Working Capital	$27.5M
Quick ratio	3.05
Working Capital	$337.1M
Working Capital Turnover	$0.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-30.52%
1Y total return	15.66%
200-day SMA	2.78
3Y total return	-47.15%
50-day SMA	3.81
50-day SMA vs 200-day SMA	50over200
5Y total return	-87.31%
All Time High	165
All Time High Change	-97.81%
All Time High Date	2011-06-07
All Time Low	1.01
All Time Low Change	258.42%
All Time Low Date	2013-05-03
ATR	0.28
Beta	0.69
Beta1y	0.53
Beta2y	1.34
Ch YTD	32.6
High	3.62
High52	5.63
High52 Date	2026-03-09
High52ch	-35.7%
Low	3.38
Low52	1.64
Low52 Date	2025-05-19
Low52ch	120.87%
Ma50ch	-4.89%
Premarket Change Percent	-1.13
Premarket Price	$3.51
Premarket Volume	92,627
Price vs 200-day SMA	30.08%
RSI	49.68
RSI Monthly	44.04
RSI Weekly	54.92
Sharpe ratio	0.67x
Sortino ratio	1.08
Total Return	-25.4%
Tr YTD	32.6
Tr15y	-97.06%
Tr1m	9.04%
Tr1w	6.47%
Tr3m	43.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	2
Analyst Price Target Top	$12.5
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.16
Earnings Revenue Estimate	75,953,048x
Earnings Revenue Estimate Growth	53.99x
Operating Income	$-358M
Operating margin	-125.4
Price target	$8.78
Price Target Change	$143
Price Target Change Top	$245

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	387,993,314%
Float Percent	86.9%
Shares Insiders	6.62%
Shares Institutions	52.6%
Shares Out	446,502,396
Shares Qo Q	2.84%
Shares Yo Y	25.4%
Short Float	28.04%
Short Ratio	7.75
Short Shares	24.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-355M
Average Volume	15,484,475.15x
Bv Per Share	1.65
CAPEX	$-34.2M
Ch10y	-30.52
Ch15y	-97.06
Ch1m	9.04
Ch1w	6.47
Ch1y	15.66
Ch3m	43.08
Ch3y	-47.15
Ch5y	-87.31
Ch6m	57.39
Change	1.97%
Change From Open	2.84
Close	3.55
Days Gap	-0.85
Depreciation Amortization	36,413,000
Dollar Volume	74,892,981.8
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-358M
EBITDA	$-321.6M
EPS	$-0.93
F Score	2
FCF	$-305M
FCF EV Yield	-22.58x
FCF Per Share	$-0.68
Financing CF	251,793,000
Fiscal Year End	December
Founded	2,007
Income Tax	$-898,000
Investing CF	43,023,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2013-09-26
Last Split Type	Reverse
Last10k Filing Date	2026-02-24
Ma150	2.91
Ma150ch	24.57%
Ma20	3.62
Ma20ch	-0.11%
Net CF	24,451,000
Next Earnings Date	2026-08-06
Open	3.52
Optionable	Yes
Position In Range	100
Post Close	3.62
Postmarket Change Percent	-0.55
Postmarket Price	$3.6
Ppne	175,776,000
Pre Close	3.55
Price Date	2026-05-08
Ptbv Ratio	3.57
Relative Volume	1.34x
Revenue	285,608,000x
SBC By Revenue	17.48x
Share Based Comp	49,929,000
Tax By Revenue	-0.31x
Tr6m	57.39%
Us State	California
Volume	20,688,669
Z Score	-2.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IOVA pay a dividend?

Capital-return profile for this ticker.

Performance

IOVA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IOVA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+52.6%

Float: +86.9% of shares outstanding

Insider ownership

+6.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IOVA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.7

Neutral momentum band

Price vs 200-day MA

+30.1%

50/200-day relationship not available

Beta (5Y)

0.69

Less volatile than the market

Sharpe ratio

0.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IOVA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IOVA stock rating?

Iovance Biotherapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IOVA analysis?

The full report lives at /stocks/IOVA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IOVA?

The latest report frames IOVA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IOVA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.